DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Medtronic Cardiac Ablation Solutions
Study ID
NCT03643224
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Radiofrequency Ablation — DEVICE
    A procedure will be performed using a radiofrequency ablation catheter.

Study Details

The purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.

Key Dates

Start date
Sep 19, 2018
Status verified
Oct 2025
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024

Study Design

Enrollment
376 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Experimental
    Radiofrequency Ablation. Catheter ablation to treat persistent atrial fibrillation using temperature-controlled ablation catheter

Primary Outcome Measure

Primary Safety Events [ Time Frame: Ablation through 6 months ]

Locations (15)

FacilityCityStateZIP
Grandview Medical CenterBirminghamAlabama35242
University Of AlabamaBirminghamAlabama35294
Keck School Of MedicineLos AngelesCalifornia90033
Advent Health, Florida Hospital OrlandoOrlandoFlorida32751
Iowa Heart CenterWest Des MoinesIowa50266
Kansas City Heart Rhythm InstituteOverland ParkKansas66211
Massachusetts General HospitalBostonMassachusetts02114
Jackson Heart ClinicJacksonMississippi39216
North Mississippi Medical CenterTupeloMississippi38801
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Montefiore Medical CenterNew YorkNew York10467
Medical University Of South CarolinaCharlestonSouth Carolina29425
Trident Medical CenterCharlestonSouth Carolina29406
Texas Cardiac Arrhythmia Research FoundationAustinTexas78705
Houston Methodist HospitalHoustonTexas77030

Find similar trials in Birmingham, AL

Related Studies